000 01620 a2200493 4500
005 20250518013053.0
264 0 _c20190326
008 201903s 0 0 eng d
022 _a1177-8881
024 7 _a10.2147/DDDT.S178862
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHuang, Jie
245 0 0 _aPharmacokinetics of single- and multiple-dose roflumilast: an open-label, three-way crossover study in healthy Chinese volunteers.
_h[electronic resource]
260 _bDrug design, development and therapy
_c2018
300 _a4047-4057 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAminopyridines
_xadministration & dosage
650 0 4 _aBenzamides
_xadministration & dosage
650 0 4 _aChina
650 0 4 _aCross-Over Studies
650 0 4 _aCyclopropanes
_xadministration & dosage
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFemale
650 0 4 _aHealthy Volunteers
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMolecular Structure
650 0 4 _aTablets
650 0 4 _aYoung Adult
700 1 _aFu, Cheng-Xiao
700 1 _aYang, Xiao-Yan
700 1 _aCui, Chan
700 1 _aYang, Shuang
700 1 _aKuang, Yun
700 1 _aGuo, Cheng-Xian
700 1 _aHu, Pei
700 1 _aPei, Qi
700 1 _aYang, Guo-Ping
773 0 _tDrug design, development and therapy
_gvol. 12
_gp. 4047-4057
856 4 0 _uhttps://doi.org/10.2147/DDDT.S178862
_zAvailable from publisher's website
999 _c29151575
_d29151575